Follitropin beta Subcutaneous and Moxetumomab pasudotox
Determining the interaction of Follitropin beta Subcutaneous and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: follicle stimulating hormone
Brand name: Follistim AQ Cartridge, Gonal-F, Gonal-f RFF, Follistim, Follistim AQ, Puregon, Gonal-f RFF Pen, Gonal-F Pen, Gonal-F, PUREGON, Gonal-F, Gonal-f RFF Rediject
Synonyms: Follicle stimulating hormone, Follitropin Alfa
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Follitropin beta Subcutaneous-Moxetumomab Pasudotox-tdfk
- Follitropin beta Subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Follitropin beta Subcutaneous-Moxifloxacin
- Follitropin beta Subcutaneous-Moxifloxacin (Systemic)
- Follitropin beta Subcutaneous-Moxifloxacin Hydrochloride
- Follitropin beta Subcutaneous-Moxifloxacin Injection
- Moxetumomab pasudotox-Folotyn
- Moxetumomab pasudotox-Folplex
- Moxetumomab pasudotox-Folplex 2.2
- Moxetumomab pasudotox-Foltabs 800
- Moxetumomab pasudotox-Foltabs Prenatal
- Moxetumomab pasudotox-Foltabs Prenatal Plus DHA